The efficacy and safety of insulin glargine 100 U/mL + lixisenatide versus insulin degludec + insulin aspart in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli-D randomized controlled trial.
作者信息
Mu Yiming
机构信息
Department of Endocrinology, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China.
出版信息
Diabetes Obes Metab. 2024 Nov;26(11):5497-5499. doi: 10.1111/dom.15857. Epub 2024 Aug 19.
PMID:39157869
Abstract
摘要
Zotero 插件